Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/07/2012CA2828478A1 Serine/threonine kinase inhibitors
09/07/2012CA2828456A1 Benzimidazole inhibitors of the sodium channel
09/07/2012CA2828326A1 Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
09/07/2012CA2828316A1 Prucalopride oral solution
09/07/2012CA2828296A1 Method for administration of a gamma secretase inhibitor
09/07/2012CA2828060A1 Endoparasite control agent
09/07/2012CA2828050A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
09/07/2012CA2827892A1 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
09/07/2012CA2827718A1 3-amino-pyridines as gpbar1 agonists
09/07/2012CA2827653A1 Proteasome inhibitor delanzomib for use in the treatment of lupus
09/07/2012CA2827533A1 Enhanced biodistribution of oligomers
09/07/2012CA2827285A1 Compositions and methods for non-surgical treatment of ptosis
09/07/2012CA2826464A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012CA2826459A1 Pharmaceutically active disubstituted pyridine derivatives
09/07/2012CA2825979A1 Gene cluster for biosynthesis of cycloclavine
09/07/2012CA2824360A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/07/2012CA2824239A1 Bridged piperidine derivatives
09/07/2012CA2823480A1 Novel benzodioxole piperidine compounds
09/07/2012CA2820709A1 Substituted quinoline compounds and methods of use
09/06/2012US20120227119 Methods of Modulating the Sex of Avians
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120226245 Transdermally absorbable preparation
09/06/2012US20120226217 Photosensitizing compositions
09/06/2012US20120226039 N-Phenyl-2-pyrimidine-amine Derivatives
09/06/2012US20120225951 Parenteral Administration of Tapentadol
09/06/2012US20120225950 Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
09/06/2012US20120225949 Compositions and methods for treating bipolar disorder
09/06/2012US20120225947 Retinal neuroprotection by ion channel blockers regulated by the sur subunit
09/06/2012US20120225946 Choline fenofibrate delayed release compositions
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/06/2012US20120225944 Triacyglycerol-based alternative to paraffin wax
09/06/2012US20120225941 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
09/06/2012US20120225940 Use of (-) (3-Trihalomethylphenoxy) (4-Halophenyl) Acetic Acid Derivatives for Treatment of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia and Hyperuricemia
09/06/2012US20120225939 Use of Prostaglandins F2Alpha and Analogues for the Healing of Corneal and Conjunctival Lesions
09/06/2012US20120225938 Method for treating central nervous system disorders
09/06/2012US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists
09/06/2012US20120225936 Method for producing triptolide
09/06/2012US20120225935 Antimicrobial and radioprotective compounds
09/06/2012US20120225934 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof
09/06/2012US20120225933 Regulated expression systems
09/06/2012US20120225932 Process for the production of polyamines
09/06/2012US20120225931 Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
09/06/2012US20120225930 Method of treating or retarding the development of blindness
09/06/2012US20120225929 Nucleic Acid Inhibitors Of Glutamate Receptors
09/06/2012US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
09/06/2012US20120225927 Compositions and methods for inhibiting expression of transthyretin
09/06/2012US20120225926 Amphiphilic macromolecules for nucleic acid delivery
09/06/2012US20120225925 Micro-RNA Biomarkers and Methods of Using Same
09/06/2012US20120225924 Single-monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery
09/06/2012US20120225923 Dithiinetetra(thio)carboximides
09/06/2012US20120225922 Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
09/06/2012US20120225920 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225919 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225918 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225916 Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
09/06/2012US20120225915 Compositions and Methods of Using R(+) Pramipexole
09/06/2012US20120225914 Treatment of sunburn using analgesics and antihistamines
09/06/2012US20120225913 Trypsin-like serine protease inhibitors, and their preparation and use
09/06/2012US20120225912 Novel colchicine derivatives, methods and uses thereof
09/06/2012US20120225911 Replenishing body stores of fat-soluble vitamins A, and D eradicate chronic viral infection
09/06/2012US20120225910 Substituted Heteroaryls
09/06/2012US20120225909 Indazole analog
09/06/2012US20120225908 Hydroxyl compounds and compositions for cholesterol management and related uses
09/06/2012US20120225907 Benzamide compounds useful as histone deacetylase inhibitors
09/06/2012US20120225906 Piperidine renin inhibitors
09/06/2012US20120225905 Bepotastine compositions
09/06/2012US20120225904 New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives
09/06/2012US20120225903 Novel 2-Substituted Quinoline Derivatives, And Method For Preparing Same
09/06/2012US20120225902 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
09/06/2012US20120225901 Dosage form containing oxycodone and naloxone
09/06/2012US20120225900 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/06/2012US20120225899 Compounds and Compositions as Protein Kinase Inhibitors
09/06/2012US20120225898 Hair growth and/or regrowth compositions
09/06/2012US20120225897 Hair growth and/or regrowth compositions
09/06/2012US20120225896 Novel 2-pyridone derivative and pharmaceutical product containing same
09/06/2012US20120225894 Substituted Thienol[2,3-d] pyrimidines as HIV Inhibitors
09/06/2012US20120225893 Combination of an antipsychotic and an anti-inflammatory agent
09/06/2012US20120225892 [1,5]-Diazocin Derivatives
09/06/2012US20120225890 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/06/2012US20120225888 Inhibitors of Human Immunodeficiency Virus Replication
09/06/2012US20120225887 Glucokinase Activators
09/06/2012US20120225886 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
09/06/2012US20120225885 Imidazole derivatives and methods of use thereof
09/06/2012US20120225884 Bridged piperidine derivatives
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225882 Selective hydroxamate based mmp inhibitors
09/06/2012US20120225881 Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hyrdroxy-2-amino-propionic acid amides and related compounds
09/06/2012US20120225880 Pyrazole compounds and thiazole compounds as protein kinases inhibitors
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225878 Compounds
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225874 Bicyclic derivatives as cetp inhibitors
09/06/2012US20120225873 Compounds for alzheimer's disease
09/06/2012US20120225872 Methods of preparing and using quinazoline and quinoline derivatives
09/06/2012US20120225871 Small-molecule modulators of trp-p8 activity
09/06/2012US20120225870 Methods for treating cancer resistant to erbb therapeutics
09/06/2012US20120225869 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/06/2012US20120225868 Novel benzodioxole piperidine compounds
1 ... 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 ... 7860